A novel cancer/testis antigen KP-OVA-52 identified by SEREX in human ovarian cancer is regulated by DNA methylation Journal Article


Authors: Kim, K. M.; Song, M. H.; Kim, M. J.; Daudi, S.; Miliotto, A.; Old, L.; Odunsi, K.; Lee, S. Y.
Article Title: A novel cancer/testis antigen KP-OVA-52 identified by SEREX in human ovarian cancer is regulated by DNA methylation
Abstract: SEREX has proven to be a powerful method that takes advantage of the presence of spontaneous humoral immune response in some cancer patients. In this study, immunoscreening of normal testis and two ovarian cancer cell line cDNA expression libraries with sera from ovarian cancer patients led to the isolation of 75 independent antigens, designated KP-OVA-1 through KP-OVA-75. Of these, RT-PCR showed KP-OVA-52 to be expressed strongly in normal testis, in ovarian cancer cell lines (3/9) and in ovarian cancer tissues (1/17). The expression of KP-OVA-52 in cancer cells is also induced by the demethylating agent 5-aza-2′-deoxycytidine (ADC). To test immunogenicity, we used the Serum Antibody Detection Assay (SADA) to analyze anti-IgG antibodies against the 75 antigens that were initially isolated by SEREX. Four of the 75 antigens (KP-OVA-25, KP-OVA-35, KP-OVA-68 and KP-OVA-73) reacted exclusively with sera from cancer patients. However, KP-OVA-52 reacted with 1 of 20 ovarian cancer sera. These data suggest that the KP-OVA-52 can be considered a novel CT antigen that is regulated by DNA methylation.
Keywords: controlled study; human tissue; protein expression; unclassified drug; human cell; ovarian neoplasms; gene; reverse transcription polymerase chain reaction; ovary cancer; gene library; cell line, tumor; dna methylation; antigens, neoplasm; recombinant fusion proteins; messenger rna; rna, messenger; cancer testis antigen; immunogenicity; cancer cell; western blotting; testicular neoplasms; 5 aza 2' deoxycytidine; immunoassay; cancer/testis antigen; serum; serology; antibodies, neoplasm; immunoglobulin g antibody; azacitidine; complementary dna; serologic analysis of recombinant cdna expression; kp ova 52 antigen; serologic analysis of recombinant cdna expression library
Journal Title: International Journal of Oncology
Volume: 41
Issue: 3
ISSN: 1019-6439
Publisher: Spandidos Publications  
Date Published: 2012-09-01
Start Page: 1139
End Page: 1147
Language: English
DOI: 10.3892/ijo.2012.1508
PROVIDER: scopus
PUBMED: 22684412
PMCID: PMC4144267
DOI/URL:
Notes: --- - "Export Date: 4 September 2012" - "CODEN: IJONE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Lloyd J Old
    593 Old